Sun BioPharma【SNBP】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

3.45

買値

3.09

売値

3.95

出来高

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

17.692M

前日終値

3.45

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

発行済株式数

5,128,000

配当利回り

PER

-0.23

1 株当たり利益 (EPS)

-4.93

歳入

純利益

-25.26M

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

本社

Dover, Delaware, USA

設立

Panbela Therapeutics, Inc. Completes Enrollment in its Phase 1b Trial Investigating SBP-101 Combination Therapy for First Lin...

MINNEAPOLIS, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of...

Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc.

MINNEAPOLIS, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients...

Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results

MINNEAPOLIS, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients...

Sun BioPharma, Inc. to Participate in the 11th Annual Craig-Hallum Alpha Select Conference

MINNEAPOLIS, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with...

Sun BioPharma, Inc. Schedules Conference Call on November 12, 2020 to Report 2020 Third Quarter Financial Results

MINNEAPOLIS, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with...

Sun BioPharma, Inc. Closes $10.5 Million Public Offering of Common Stock and Warrants

MINNEAPOLIS, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients...

China's Basic Medical Insurance to Cover Sinobiopharma's Flagship Product

Basic Insurance to Cover 90 Percent of China's Urban Population of 600 Million by the End of 2010 NANTONG, China, Feb. 1 /PRNewswire-Asia/ -- Sinobiopharma, Inc. ("Sinobiopharma" or, the...

Chinese State Food and Drug Administration Approves Company Facility for Producing Solid Dosage Perindopril

NANTONG, China, Jan. 25 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc. ("Sinobiopharma" or, the "Company") (OTC:SNBP) (BULLETIN BOARD: SNBP) is pleased to announce that its production...

Sinobiopharma Announces Second Quarter 2010 Financial Results

Revenue Increases to Approximately $2.1 Million; Net Income Increases to Approximately $1.1 Million NANTONG CITY, China, Jan. 19 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc. (OTC Bulletin...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
SPPLSIMPPLE Ltd	US$ 1.18 (268.75%)	401.72M
NUWENewellis Inc	US$ 2.80 (105.88%)	100.16M
ADNAdvent Technologies Holdings Inc	US$ 3.34 (75.79%)	66.85M
STAFStaffing 360 Solutions Inc	US$ 2.8301 (66.48%)	53.1M
OMICSingular Genomics Systems Inc	US$ 22.28 (65.53%)	323.91k
TOIIWOncology Institute Inc	US$ 0.0101 (-47.67%)	58.23k
SSPEW Scripps Company	US$ 2.2701 (-35.51%)	4.27M
GCTKGlucoTrack Inc	US$ 1.15 (-33.91%)	82.44k
ILLRTriller Group Inc	US$ 2.86 (-33.18%)	2.33M
FGFFundamental Global Inc	US$ 15.2501 (-31.46%)	211.15k
SPPLSIMPPLE Ltd	US$ 1.18 (268.75%)	401.72M
ELABElevai Labs Inc	US$ 0.0202 (-30.10%)	290.65M
NVDANVIDIA Corporation	US$ 136.05 (0.48%)	187.52M
SQQQProShares UltraPro Short QQQ	US$ 7.52 (1.08%)	167.3M
DJTTrump Media and Technology Group Corporation	US$ 34.34 (12.37%)	120.92M